AstraZeneca: AstraZeneca strategically acquired Spirogen, a pioneer in PBD-based ADC technology, allowing them to enter the ADC field. They also invested inADC Therapeuticsand collaborated with Daiichi Sankyo, further expanding their presence in the ADC market. AbbVie and Gilead: These companies secu...
Paul appeared to be out of options. With each long and unpleasant round of treatment, his doctors had been working their way down a list of common cancer drugs, hoping to hit on something that would prove effective—and crossing them off one by one. The usual...
British pharma giant AstraZeneca is paying $39 billion toacquire Alexion Pharmaceuticals, a publicly traded Boston biotech with about 3,800 employees that focuses on rare diseases affecting the kidneys, nervous system, and blood. That deal, expected to close this summer, will create a rare disease...